Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution Breastfeeding
American Academy of Pediatrics and other medical experts exclusively recommend to breastfeed the baby for first 6 months. Once you introduce baby to other foods it is recommended to breastfeed for at least first year of babys life. Taking medication while breastfeeding could be tricky as most drugs pass in breast milk. In this article we will evaluate Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution for its safety in breastfeeding.

What is Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution ?


Valganciclovir hydrochloride for oral solution is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated for: Pediatric Patients (1.2) Prevention of CMV disease in kidney and heart transplant patients at high risk 1.2 Pediatric Patients Prevention of CMV Disease: Valganciclovir hydrochloride is indicated for the prevention of CMV disease in kidney transplant patients (4 months to 16 years of age) and heart transplant patients (1 month to 16 years of age) at high risk [see Clinical Studies (14.2)].

Can I use Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution while breastfeeding?

Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution low risk for breastfeeding
Valganciclovir is the one and only active ingredient present in Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution. Valganciclovir in itself is a low risk drug for lactation so it is easy to understand that Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution also comes in category of Low Risk item while breastfeeding. Below is the summary of Valganciclovir in breastfeeding.

Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution Breastfeeding Analsys


Valganciclovir while Breastfeeding

Low Risk

CAS Number: 175865-60-8

Ganciclovir-related drug which is absorbable by mouth. It is indicated for treatment of retinitis caused by Citomegalovirus.

Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution Breastfeeding Analsys - 2


Valganciclovir while Breastfeeding

CAS Number: 175865-60-8

Valganciclovir is rapidly converted to ganciclovir. Several factors might affect the decision to use valganciclovir in a nursing mother. No information is available on the clinical use of ganciclovir or valganciclovir during breastfeeding. Cytomegalovirus (CMV) can be transmitted to infants though breastmilk, with preterm and immunocompromised infants at greatest risk. No information is available on any changes in the risk of transmission if the mother is being treated with ganciclovir or valganciclovir. Although the manufacturer recommends avoiding breastfeeding during valganciclovir use because of the risk of infant drug toxicity, neonates with CMV infections are often treated directly with ganciclovir or valganciclovir. If the mother has a concurrent infection with HIV, breastfeeding is not recommended in the United States and other developed countries.


I already used Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution and meanwhile I breastfed my baby should I be concerned?

During whole lactation period you shall first discuss with your doctor and then together you shall decide whether you shall take that drug or not however if you have already taken Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution then you shall inform your doctor, But you should not be worried too much as Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution comes in category of low risk drug.


My doctor has prescribed me Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution, what should I do?

Though Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.


If I am using Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution, will my baby need extra monitoring?

Not much


Who can I talk to if I have questions about usage of Valganciclovir Hydrochloride For Oral | Valganciclovir Hydrochloride Powder, For Solution in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Valcyte | Valganciclovir Tablet